𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Ursodeoxycholic acid reduces increased circulating endothelin 2 in primary biliary cirrhosis

✍ Scribed by P. Dimoulios; G. Kolios; G. Notas; E. Matrella; C. Xidakis; M. Koulentaki; N. Tsagarakis; A. Kouroumalis; E. Kouroumalis


Book ID
108603937
Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
307 KB
Volume
21
Category
Article
ISSN
0269-2813

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Ursodeoxycholic acid therapy in primary
✍ David E. J. Jones; Oliver F. W. James; Margaret F. Bassendine πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 703 KB

BackgroundlAims: A double-blind, placebo-controlled trial of ursodeoxycholic acid (UDCA) was conducted in 180 patients with primary biliary cirrhosis (PBC) to define the efficacy and safety of UDCA Efficacy was assessed by time to treatment failure defined as death; liver transplantation; histologic